Literature DB >> 15997402

[Antibacterial photodynamic therapy. A new treatment for superficial bacterial infections?].

T Maisch1, R-M Szeimies, N Lehn, C Abels.   

Abstract

The basis of "antibacterial photodynamic therapy" involves the killing of bacteria by reactive oxygen species in the presence of a photosensitizer and light. Possible dermatologic indications include inactivation of bacteria in skin and wound infections and reduction in density of nosocomial multi-resistant infections. The chief advantage of antibacterial photodynamic therapy is that regardless of the resistance pattern of a bacteria, inactivation can be achieved, analogous to the use of antiseptics. The aim of the present review is to describe the physicochemical and biological mechanisms of antibacterial photodynamic therapy as well as possible clinical indications in dermatology.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15997402     DOI: 10.1007/s00105-005-0977-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  53 in total

1.  [Characterization of nonresponders in high dosage UVA1 therapy of acute exacerbated atopic dermatitis].

Authors:  C M Schempp; T Effinger; W Czech; J Krutmann; J C Simon; E Schöpf
Journal:  Hautarzt       Date:  1997-02       Impact factor: 0.751

Review 2.  Molecular basis of bacterial outer membrane permeability.

Authors:  H Nikaido; M Vaara
Journal:  Microbiol Rev       Date:  1985-03

3.  Allergic contact dermatitis to some medicaments.

Authors:  G Angelini; G A Vena; C L Meneghini
Journal:  Contact Dermatitis       Date:  1985-05       Impact factor: 6.600

4.  Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin.

Authors:  K J Harder; H Nikaido; M Matsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

5.  9-Acetoxy-2,7,12,17-tetrakis-(beta-methoxyethyl)-porphycene (ATMPn), a novel photosensitizer for photodynamic therapy: uptake kinetics and intracellular localization.

Authors:  R M Szeimies; S Karrer; C Abels; P Steinbach; S Fickweiler; H Messmann; W Bäumler; M Landthaler
Journal:  J Photochem Photobiol B       Date:  1996-06       Impact factor: 6.252

6.  Photoinactivation of Acinetobacter baumannii and Escherichia coli B by a cationic hydrophilic porphyrin at various light wavelengths.

Authors:  Y Nitzan; H Ashkenazi
Journal:  Curr Microbiol       Date:  2001-06       Impact factor: 2.188

Review 7.  Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications.

Authors:  H F Chambers
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

8.  Photodynamic action of methylene blue: repair and mutation in Escherichia coli.

Authors:  S Menezes; M A Capella; L R Caldas
Journal:  J Photochem Photobiol B       Date:  1990-05       Impact factor: 6.252

9.  Polycations as outer membrane-disorganizing agents.

Authors:  M Vaara; T Vaara
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191

Review 10.  In vitro approaches for determining mechanisms of toxicity and carcinogenicity by asbestos in the gastrointestinal and respiratory tracts.

Authors:  B T Mossman
Journal:  Environ Health Perspect       Date:  1983-11       Impact factor: 9.031

View more
  1 in total

1.  Photodynamic therapy as an antifungal treatment.

Authors:  Y I Liang; Li-Ming Lu; Yong Chen; You-Kun Lin
Journal:  Exp Ther Med       Date:  2016-05-11       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.